TY - JOUR
T1 - Paracrine action enhances the effects of autologous mesenchymal stem cell transplantation on vascular regeneration in rat model of myocardial infarction
AU - Yao, Liang Tang
AU - Zhao, Qiang
AU - Qin, Xinyu
AU - Shen, Leping
AU - Cheng, Leilei
AU - Ge, Junbo
AU - Phillips, M. Ian
N1 - Funding Information:
Yao Liang Tang is supported by an American Heart Association postdoctoral fellowship (0325378B). This work was supported by the National Institutes of Health MERIT Award HL 27339 (MIP). We are grateful for the expert technical assistance of Guoqian Huang, MD, Chuizheng Pan, and Xianhong Shu, MD.
PY - 2005/7
Y1 - 2005/7
N2 - Background. There are several reports that engrafted mesenchymal stem cells (MSCs) stimulate angiogenesis in the ischemic heart, but the mechanism remains controversial. We hypothesize that transplantation of MSCs enhances vascular regeneration through a paracrine action. Methods. A transmural myocardial infarction was created by ligation of the left anterior descending coronary artery in rats. Those with an ejection fraction less than 0.70 1 week after myocardial infarction were included. Autologous MSCs (1 × 107; 0.2 mL) or culture medium (0.2 mL) was injected intramyocardially into the periinfarct zone (50 μL/injection at four sites; n = 20/group). At 2 weeks after transplantation, Western blot analysis was used to assay the paracrine factors and proapoptotic proteins. Echocardiography to assess heart function was performed on additional groups at 8 weeks after implantation. Results. The angiogenic factors basic fibroblast growth factor, vascular endothelial growth factor, and stem cell homing factor (stromal cell-derived factor -1α) increased in the MSC-treated hearts compared with medium-treated hearts. This was accompanied by a downregulation of proapoptotic protein Bax in ischemic myocardium. Similarly, capillary density increased about 40% in MSC-treated hearts compared with medium-treated hearts (p = 0.001). Left ventricular contractility, indicated by fractional shortening, improved in MSC-treated hearts at 2 months after implantation (MSCs: 48.6% ± 19.9%; medium: 18.7% ± 6.4%; p = 0.004). Conclusions. Autologous MSC transplantation attenuates left ventricular remodeling and improves cardiac performance. The major mechanism appears to be paracrine action of the engrafted cells, increasing angiogenesis and cytoprotection.
AB - Background. There are several reports that engrafted mesenchymal stem cells (MSCs) stimulate angiogenesis in the ischemic heart, but the mechanism remains controversial. We hypothesize that transplantation of MSCs enhances vascular regeneration through a paracrine action. Methods. A transmural myocardial infarction was created by ligation of the left anterior descending coronary artery in rats. Those with an ejection fraction less than 0.70 1 week after myocardial infarction were included. Autologous MSCs (1 × 107; 0.2 mL) or culture medium (0.2 mL) was injected intramyocardially into the periinfarct zone (50 μL/injection at four sites; n = 20/group). At 2 weeks after transplantation, Western blot analysis was used to assay the paracrine factors and proapoptotic proteins. Echocardiography to assess heart function was performed on additional groups at 8 weeks after implantation. Results. The angiogenic factors basic fibroblast growth factor, vascular endothelial growth factor, and stem cell homing factor (stromal cell-derived factor -1α) increased in the MSC-treated hearts compared with medium-treated hearts. This was accompanied by a downregulation of proapoptotic protein Bax in ischemic myocardium. Similarly, capillary density increased about 40% in MSC-treated hearts compared with medium-treated hearts (p = 0.001). Left ventricular contractility, indicated by fractional shortening, improved in MSC-treated hearts at 2 months after implantation (MSCs: 48.6% ± 19.9%; medium: 18.7% ± 6.4%; p = 0.004). Conclusions. Autologous MSC transplantation attenuates left ventricular remodeling and improves cardiac performance. The major mechanism appears to be paracrine action of the engrafted cells, increasing angiogenesis and cytoprotection.
UR - http://www.scopus.com/inward/record.url?scp=20544450374&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=20544450374&partnerID=8YFLogxK
U2 - 10.1016/j.athoracsur.2005.02.072
DO - 10.1016/j.athoracsur.2005.02.072
M3 - Article
C2 - 15975372
AN - SCOPUS:20544450374
SN - 0003-4975
VL - 80
SP - 229
EP - 237
JO - Annals of Thoracic Surgery
JF - Annals of Thoracic Surgery
IS - 1
ER -